Researchers recently studied patient-reported outcomes instruments to determine effectiveness of lumbar fusion for degenerative spondylolisthesis in registry efforts. The results were published in The Spine Journal.
There were 58 patients participating in the study who underwent primary transforaminal lumbar interbody fusion for lumbar spondylolisthesis. The patients were entered into an institutional registry and followed for two years. The researchers ODI had AUC=0.94, suggesting it is an acute discriminator of meaningful treatment.
The most responsive to postoperative improvement was ODI, then NRS-BP and NRS-LP. EQ-5D was most accurate and EQ-5D was most responsive for general health and quality of life, although SF-12, Zung and SF-12 MCS were also accurate discriminators.
More Articles on Spine Surgery:
Cervical Spine Surgery: Factors, Risks of Postoperative Airway Management
Cervical Spinal Fusion: rhBMP Associated With Complications
CPT Editorial Panel Updates for Spine: Key Concepts for 2015